{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:44:48Z","timestamp":1791935088915,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbi.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T22:24:38Z","timestamp":1588631078000},"page":"930-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies"],"prefix":"10.1016","volume":"88","author":[{"given":"Shay","family":"Gur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Taler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Bormant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dori","family":"Blattberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Nitzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livnat","family":"Brill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Krivoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldar","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.05.001_b0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.05.007","article-title":"Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica","volume":"283","author":"Akaishi","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2020.05.001_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fpsyt.2017.00013","article-title":"Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses","volume":"8","author":"Al-Diwani","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jad.2019.07.008","article-title":"Electroconvulsive shock restores the decreased coverage of brain blood vessels by astrocytic endfeet and ameliorates depressive-like behavior","volume":"257","author":"Azis","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.05.001_b0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ijnp\/pyx083","article-title":"Interferon-Alpha Reduces Human Hippocampal Neurogenesis and Increases Apoptosis via Activation of Distinct STAT1-Dependent Mechanisms","volume":"21","author":"Borsini","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2020.05.001_b0030","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/NDT.S82380","article-title":"Autoimmune encephalitis in psychiatric institutions: current perspectives","volume":"12","author":"Bost","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2020.05.001_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/1040-3590.19.2.247","article-title":"The PHQ-9 as a brief assessment of lifetime major depression","volume":"19","author":"Cannon","year":"2007","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.bbi.2020.05.001_b0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.bbi.2020.05.001_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1399-5618.2012.01028.x","article-title":"Antibodies to the glutamate receptor in mania","volume":"14","author":"Dickerson","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2020.05.001_b0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000493740","article-title":"Glutamate-related antibodies and peripheral insulin-like growth factor in bipolar disorder and lithium prophylaxis","volume":"77","author":"Ferensztajn-Rochowiak","year":"2019","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbi.2020.05.001_b0060","doi-asserted-by":"crossref","unstructured":"Grunze, H., Vieta, E., Goodwin, G.M., Bowden, C., Licht, R.W., M\u00f6ller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guidelines for Bipolar Disorders, 2013. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J. Biol. Psychiatry 14, 154\u2013219. https:\/\/doi.org\/10.3109\/15622975.2013.770551.","DOI":"10.3109\/15622975.2013.770551"},{"key":"10.1016\/j.bbi.2020.05.001_b0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.biopsych.2014.09.011","article-title":"Treatment-Resistant Depression and Aquaporin-4 Autoantibodies: Is There a Link?","volume":"78","author":"Iorio","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.mp.4001437","article-title":"Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders","volume":"9","author":"Iwamoto","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms17030273","article-title":"The immunology of neuromyelitis optica\u2014current knowledge, clinical implications, controversies and future perspectives","volume":"17","author":"Jasiak-Zatonska","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2020.05.001_b0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/JIR.S141033","article-title":"The role of neuroinflammation and neurovascular dysfunction in major depressive disorder","volume":"11","author":"Jeon","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bbi.2020.05.001_b0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1176\/appi.ajp.2015.15020152","article-title":"Inflammation: depression fans the flames and feasts on the heat","volume":"172","author":"Kiecolt-Glaser","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0090","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1242\/jcs.035758","article-title":"AQP4 knockout impairs proliferation, migration and neuronal differentiation of adult neural stem cells","volume":"121","author":"Kong","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbi.2020.05.001_b0095","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/npp.2008.185","article-title":"Requirement of AQP4 for antidepressive efficiency of fluoxetine: implication in adult hippocampal neurogenesis","volume":"34","author":"Kong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2020.05.001_b0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fpsyt.2018.00451","article-title":"Depressive syndromes in autoimmune disorders of the nervous system: prevalence, etiology, and influence","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0105","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.bbi.2020.05.001_b0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.schres.2017.04.027","article-title":"Anti-neuronal anti-bodies in patients with early psychosis","volume":"192","author":"Mantere","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2020.05.001_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpsychires.2015.10.010","article-title":"Evidence for alterations of the glial syncytial function in major depressive disorder","volume":"72","author":"Medina","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2020.05.001_b0120","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.3390\/ijms16059949","article-title":"Pathogenesis of brain edema and investigation into anti-edema drugs","volume":"16","author":"Michinaga","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2020.05.001_b0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0130","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","article-title":"Physiological roles of aquaporin-4 in brain","volume":"93","author":"Nagelhus","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbi.2020.05.001_b0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.biopsych.2004.07.003","article-title":"A high prevalence of organ-specific autoimmunity in patients with bipolar disorder","volume":"56","author":"Padmos","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder?","volume":"2015","author":"Patel","year":"2015","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.bbi.2020.05.001_b0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2012.09.024","article-title":"Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder","volume":"73","author":"Rajkowska","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/YIC.0b013e328341bb5f","article-title":"Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale","volume":"26","author":"Sheehan","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2020.05.001_b0160","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2016.02.011","article-title":"Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression","volume":"293","author":"Shi","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2020.05.001_b0170","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.psychres.2017.10.043","article-title":"No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder","volume":"259","author":"Snijders","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2020.05.001_b0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1092852917000876","article-title":"New medications for treatment-resistant depression: a brief review of recent developments","volume":"22","author":"Thase","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbi.2020.05.001_b0180","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.8001tx12c","article-title":"Newer medications for complicated depression","volume":"70","author":"Thase","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.001_b0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2014.05.004","article-title":"NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases","volume":"54","author":"Vaknin-Dembinsky","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbi.2020.05.001_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040164","article-title":"Association of Genetic Variation at AQP4 Locus with Vascular Depression","volume":"8","author":"Westermair","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbi.2020.05.001_b0195","unstructured":"World Health Organization, W.H.O., 2018. World Health Organization. Adverse Childhood Experiences International Questionnaire. In Adverse Childhood Experiences International Questionnaire (ACE-IQ). [website]: Geneva: WHO, 2018. http:\/\/www.who.int\/violence_injury_prevention\/violence\/activities\/adverse_childhood_experiences\/en\/."},{"key":"10.1016\/j.bbi.2020.05.001_b0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-016-4473-9","article-title":"Mechanism of depression as a risk factor in the development of Alzheimer\u2019s disease: the function of AQP4 and the glymphatic system","volume":"234","author":"Xia","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2020.05.001_b0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cns.12267","article-title":"Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders","volume":"20","author":"Xiao","year":"2014","journal-title":"CNS Neurosci. Ther."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120304955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120304955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:08:17Z","timestamp":1760170097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120304955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"alternative-id":["S0889159120304955"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.05.001","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}